NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
121 Uppsala

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 168 1.4% 301 2.5% 38 0.3% 1 0.0% 1 0.0% 2 0.0% 11437 95.7% 11948 100.0%
ASCUS 89 8.2% 403 37.0% 186 17.1% 5 0.5% 3 0.3% 1 0.1% 402 36.9% 1089 100.0%
LSIL 38 4.8% 340 43.3% 246 31.3% 1 0.1% 1 0.1% . . 159 20.3% 785 100.0%
Atypical glandular cells/AGC 1 10.0% 1 10.0% . . 6 60.0% 1 10.0% . . 1 10.0% 10 100.0%
ASC-H 4 3.1% 30 23.1% 89 68.5% 3 2.3% . . . . 4 3.1% 130 100.0%
HSIL 4 1.9% 22 10.4% 167 79.1% 9 4.3% 8 3.8% . . 1 0.5% 211 100.0%
Suspected Adenocarcinom . . 1 12.5% . . 4 50.0% 2 25.0% . . 1 12.5% 8 100.0%
Squamous cell cancer . . . . . . . . 4 80.0% . . 1 20.0% 5 100.0%
Totalt 304 2.1% 1098 7.7% 726 5.1% 29 0.2% 20 0.1% 3 0.0% 12006 84.6% 14186 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the category Cancer:
M80009, M80703, M81403, M81407, M98233